5-Methyl-1,3,4-oxadiazol-2(3H)-one

Introduction

CAS No. :	3069-67-8	MDL No. :	MFCD07779431
Formula :	C3H4N2O2	Boiling Point :	-
Linear Structure Formula :	-	InChI Key :	NNXROHRFMWHXNH-UHFFFAOYSA-N
M.W :	100.08	Pubchem ID :	5323974
Synonyms :

Physicochemical Properties

Num. heavy atoms :	7
Num. arom. heavy atoms :	5
Fraction Csp3 :	0.33
Num. rotatable bonds :	0
Num. H-bond acceptors :	3.0
Num. H-bond donors :	1.0
Molar Refractivity :	22.09
TPSA :	58.89 Ų

Pharmacokinetics

GI absorption :	High
BBB permeant :	No
P-gp substrate :	No
CYP1A2 inhibitor :	No
CYP2C19 inhibitor :	No
CYP2C9 inhibitor :	No
CYP2D6 inhibitor :	No
CYP3A4 inhibitor :	No
Log Kp (skin permeation) :	-7.07 cm/s

Lipophilicity

Log Po/w (iLOGP) :	0.88
Log Po/w (XLOGP3) :	-0.23
Log Po/w (WLOGP) :	-0.33
Log Po/w (MLOGP) :	-0.72
Log Po/w (SILICOS-IT) :	1.24
Consensus Log Po/w :	0.17

Druglikeness

Lipinski :	0.0
Ghose :	None
Veber :	0.0
Egan :	0.0
Muegge :	2.0
Bioavailability Score :	0.55

Water Solubility

Log S (ESOL) :	-0.84
Solubility :	14.3 mg/ml ; 0.143 mol/l
Class :	Very soluble
Log S (Ali) :	-0.55
Solubility :	28.3 mg/ml ; 0.282 mol/l
Class :	Very soluble
Log S (SILICOS-IT) :	-1.08
Solubility :	8.3 mg/ml ; 0.083 mol/l
Class :	Soluble

Medicinal Chemistry

PAINS :	0.0 alert
Brenk :	0.0 alert
Leadlikeness :	1.0
Synthetic accessibility :	1.9

Signal Word:	Warning	Class:	N/A
Precautionary Statements:	P261-P280-P305+P351+P338	UN#:	N/A
Hazard Statements:	H302-H315-H319-H332-H335	Packing Group:	N/A
GHS Pictogram:

Related View all 

• 

  Ghk-Cu

• 

  Gly-His-Lys acetate salt

• 

  N-Phenylacetyl-L-Prolylglycine ethyl ester

• 

  L-Phenylalanyl-L-isoleucine

• 

  L-Isoleucyl-L-phenylalanine

• 

  L-Ala-L-phe

• 

  L-Glutathione Reduced

• 

  L-Alanyl-L-tyrosine